Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruanjian Qingmai Recipe is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Hospital of Integrated Traditional Chinese and Western Medicine for the treatment of lower extremity arteriosclerosis obliterans (ASO). The recipe is formulated based on TCM principles to "soften hardness" and "clear the vessels," targeting the atherosclerotic plaques and vascular inflammation associated with ASO. Clinical and mechanistic research suggests that the formula may exert its therapeutic effects by modulating the gut microbiota and influencing systemic metabolism, thereby improving peripheral circulation and alleviating ischemic symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ruanjian Qingmai Recipe.